TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial
Article in The Lancet Infectious Diseases (December 2022)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in The Lancet Infectious Diseases (December 2022)
Article in Viruses (August 2022)